HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Tag: mutations
-
LAMBDA : NEW VARIANT WITH 7 MUTATIONS
Lambda, a new coronavirus variant has been declared as a “variant of interest” by the World Health Organization (WHO). 31 countries including United States, United Kingdom, France, Italy, Germany and Switzerland etc., have reported the cases of this variant. Originated in Peru in December 2020, now this particular variant accounts for almost 82% of the total…
-
Concern of rising SARS-CoV2 Variants and Mutations
As new variants of SARS-Cov2 the official title given to the COVID-19 virus, continue to arise, similar transformations are discovered by the scientists, making the infection more problematic and destructive. This article primarily focuses on those changes called mutations. What happens during mutations? Once a virus gets into our body, it latches onto one of…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila